Prifti Edvin, Di Lascio Gabriella, Harmelin Guy, Bani Daniele, Briganti Vittorio, Veshti Altin, Bonacchi Massimo
Division of Cardiac Surgery, University Hospital Center of Tirana, Albania.
Anesthesiology and Intensive Care Section, Department of Health Sciences, University of Florence, Florence, Italy.
Cardiovasc Revasc Med. 2016 Jun;17(4):262-71. doi: 10.1016/j.carrev.2016.02.008. Epub 2016 Feb 13.
The aim was to create a model of myocardial infarction with a borderline myocardial impairment which would enable evaluation of the retrograde cellular cardiomyoplasty through the venous coronary sinus in a large animal model.
Fifteen (study group) and 10 juvenile farm pigs (control group) underwent distal left anterior descending artery ligation. One month later the study group animals underwent sternotomy and a murine myoblastic line C2-C12 was injected at a constant pressure of 30mmHg, into the coronary sinus. Thirty days later all animals that survived from both groups underwent transthoracic echocardiography and 99Tc scintigraphy and were later euthanized and specimens were taken for microscopic evaluation.
Cardiac output decreased significantly after ligation (p<0.001) and increased significantly after cardiomyoplasty (p<0.001). In all animals, the surgical induction of myocardial infarction caused a marked decline in the echocardiographic values of cardiac function; however, the cardiac function and dimensions were significantly improved in the study group after cardiomyoplasty versus the control group. All animals undergoing cardiomyoplasty demonstrated a significant reduction of the perfusion deficit in the left anterior descending artery territory, instead such data remained unchanged in the control group. The histological examination demonstrated the engrafted myoblasts could be distinguished from the activated fibroblasts in the scar tissue because they never showed any signs of collagen secretion and fiber buildup.
In conclusion, the venous retrograde delivery route through the coronary sinus is safe and effective, providing a significant improvement in function and viability.
创建一个心肌损伤处于临界状态的心肌梗死模型,以便在大型动物模型中评估经冠状静脉窦逆行细胞心肌成形术。
15只(研究组)和10只幼年农场猪(对照组)接受左前降支动脉远端结扎。1个月后,研究组动物接受胸骨切开术,并以30mmHg的恒定压力将小鼠成肌细胞系C2-C12注入冠状静脉窦。30天后,两组所有存活的动物均接受经胸超声心动图检查和99Tc闪烁扫描,随后实施安乐死并取标本进行显微镜评估。
结扎后心输出量显著下降(p<0.001),心肌成形术后显著增加(p<0.001)。在所有动物中,手术诱导的心肌梗死导致心脏功能的超声心动图值显著下降;然而,与对照组相比,研究组在心肌成形术后心脏功能和尺寸得到显著改善。所有接受心肌成形术的动物在左前降支动脉区域的灌注缺损均显著减少,而对照组的此类数据保持不变。组织学检查表明,植入的成肌细胞可与瘢痕组织中活化的成纤维细胞区分开来,因为它们从未表现出任何胶原蛋白分泌和纤维堆积的迹象。
总之,经冠状静脉窦的静脉逆行输送途径安全有效,可显著改善功能和生存能力。